Cargando…
Renal cancer biomarkers: the promise of personalized care
Significant advances in our understanding of the biology of renal cell carcinoma (RCC) have been achieved in recent years. These insights have led to the introduction of novel targeted therapies, revolutionising the management of patients with advanced disease. Nevertheless, there are still no bioma...
Autores principales: | Vasudev, Naveen S, Selby, Peter J, Banks, Rosamonde E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521191/ https://www.ncbi.nlm.nih.gov/pubmed/23016578 http://dx.doi.org/10.1186/1741-7015-10-112 |
Ejemplares similares
-
An Exploratory Analysis of Changes in Circulating Plasma Protein Profiles Following Image-Guided Ablation of Renal Tumours Provides Evidence for Effects on Multiple Biological Processes
por: Wah, Tze Min, et al.
Publicado: (2021) -
Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer
por: Vasudev, Naveen S, et al.
Publicado: (2020) -
Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012) -
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions
por: Wind, Tobias C, et al.
Publicado: (2011) -
UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time
por: Vasudev, Naveen S., et al.
Publicado: (2020)